-
FDA accepts Teva's sNDA for pediatric QNASL
JERUSALEM — Teva Pharmaeceuticals on Tuesday announced that the Food and Drug Administration accepted the company's supplemental new drug application for a lower dose QNASL (beclomethasone dipropionate) nasal aerosol, which is used for the treatment of seasonal and perennial allergic rhinitis in children ages 4 years to 11 years.
QNASL, a waterless intranasal corticosteroid spray, is currently available to treat patients 12 years of age and older who show symptoms of seasonal allergic rhinitis and perennial allergic rhinitis, the company notes.
-
Red Carpet Manicure launches new shades for summer
HAUPPAUGE, N.Y. — Red Carpet Manicure nail care brand has announced the launch of “Sweet Indulgence,” a six-shade limited-edition collection of LED nail gel polishes for summer.
The line is available now at RedCarpetManicure.com and will roll out in June at Ulta Beauty Stores and Ulta.com.
The pastel palette draws inspiration directly from top designer fashion week shows and includes a range of warm hues like peach and lavender to trace elements of pink and sea foam tones.